Futura Medical (LON:FUM) Shares Cross Below Two Hundred Day Moving Average – What’s Next?

Futura Medical plc (LON:FUM) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 6.99 and traded as low as GBX 1.05. Futura Medical shares last traded at GBX 1.05, with a volume of 1,794,040 shares changing hands.

Futura Medical Price Performance

The stock has a market capitalization of £3.35 million, a price-to-earnings ratio of -0.53 and a beta of 1.25. The business has a fifty day moving average of GBX 2.33 and a 200 day moving average of GBX 6.99.

Futura Medical (LON:FUM) last posted its earnings results on Tuesday, September 30th. The company reported GBX (2.17) EPS for the quarter. Futura Medical had a negative net margin of 44.64% and a negative return on equity of 56.44%. On average, equities research analysts expect that Futura Medical plc will post 2.8486672 EPS for the current year.

Insider Transactions at Futura Medical

In other Futura Medical news, insider Harmesh Suniara sold 4,441,678 shares of the stock in a transaction dated Thursday, November 13th. The shares were sold at an average price of GBX 2, for a total transaction of £88,833.56. Company insiders own 1.50% of the company’s stock.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women.